BACKGROUND: Elderly patients with acute ischemic stroke often do worse than younger counterparts independent of thrombolytic therapy. Further, tissue-type plasminogen activator, (t-PA) is frequently withheld from the very old. This may be the result of comorbid conditions prohibiting its use or possibly the fear of causing more harm than good. We present a case of a 100-year-old woman who was treated with t-PA for acute ischemic stroke with rapid resolution of symptoms. CASE DESCRIPTION: A 100-year-old woman presented to the emergency department with slurred speech, right hemiparesis and right hemisensory loss. Computed tomography revealed neither hemorrhage nor early ischemic changes. Intravenous t-PA was administered at 0.9 mg/kg 3 min prior to the 3-hour limit. She improved rapidly (NIHSS from 12 on admission to 4 at 1 month) and was discharged to the care of her family after 4 hospital days. CONCLUSION: Intravenous thrombolysis may be beneficial in the very elderly and should be considered in any eligible elderly patients with acute ischemic stroke, with a risk/benefit analysis individualized to each case. Copyright 2002 S. Karger AG, Basel
BACKGROUND: Elderly patients with acute ischemic stroke often do worse than younger counterparts independent of thrombolytic therapy. Further, tissue-type plasminogen activator, (t-PA) is frequently withheld from the very old. This may be the result of comorbid conditions prohibiting its use or possibly the fear of causing more harm than good. We present a case of a 100-year-old woman who was treated with t-PA for acute ischemic stroke with rapid resolution of symptoms. CASE DESCRIPTION: A 100-year-old woman presented to the emergency department with slurred speech, right hemiparesis and right hemisensory loss. Computed tomography revealed neither hemorrhage nor early ischemic changes. Intravenous t-PA was administered at 0.9 mg/kg 3 min prior to the 3-hour limit. She improved rapidly (NIHSS from 12 on admission to 4 at 1 month) and was discharged to the care of her family after 4 hospital days. CONCLUSION: Intravenous thrombolysis may be beneficial in the very elderly and should be considered in any eligible elderly patients with acute ischemic stroke, with a risk/benefit analysis individualized to each case. Copyright 2002 S. Karger AG, Basel
Authors: D Kim; G A Ford; C S Kidwell; S Starkman; F Vinuela; G R Duckwiler; R Jahan; J L Saver Journal: AJNR Am J Neuroradiol Date: 2007-01 Impact factor: 3.825
Authors: Bijan Vatankhah; Michael S Dittmar; Nando P Fehm; Petr Erban; Guntram W Ickenstein; Wolfgang Jakob; Ulrich Bogdahn; Markus Horn Journal: J Thromb Thrombolysis Date: 2005-08 Impact factor: 2.300
Authors: B Baena Álvarez; S García-Madrona; R Sainz Amo; F Rodríguez Jorge; J Gómez Corral; R Vera Lechuga; M C Matute Lozano; A Sánchez Sánchez; A De Felipe Mimbrera; A Cruz Culebras; J Masjuan Vallejo Journal: Eur Geriatr Med Date: 2021-04-28 Impact factor: 1.710